Penumbra
PEN
#1748
Rank
S$12.61 B
Marketcap
$328.57
Share price
-0.40%
Change (1 day)
-4.21%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Cash on Hand

Cash on Hand as of September 2024 : S$0.39 Billion

According to Penumbra's latest financial reports the company has S$0.39 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Penumbra - Cash on Hand chart (from 2014 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$0.38 B51.52%
2022-12-31S$0.25 B-26.84%
2021-12-31S$0.34 B-1.65%
2020-12-31S$0.35 B37.22%
2019-12-31S$0.25 B-6.96%
2018-12-31S$0.27 B-4.38%
2017-12-31S$0.28 B54.02%
2016-12-31S$0.18 B-11.47%
2015-12-31S$0.21 B209.06%
2014-12-31S$68.1 M293.06%
2013-12-31S$17.32 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$0.15 B-61.67%๐Ÿ‡บ๐Ÿ‡ธ USA
S$0.70 B 79.75%๐Ÿ‡บ๐Ÿ‡ธ USA